Breaking
Sunday, June 21, 2026

Drug Approvals

🇺🇸 FDA Page 52

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.

Showing 613–624 of 665 articles

High impact NewsApr 11, 2026

FDA Approves SkinGuard: New Topical Treatment for Severe Eczema

FDA · Severe Eczema · 6 min

Prof. Marcus Webb
High impact NewsApr 11, 2026

FDA Approves CogniMax: New Early-Stage Alzheimer's Treatment

FDA · Alzheimer's disease · 7 min

Dr. Sarah Mitchell
High impact NewsApr 11, 2026

FDA Approves VitaRestore: New Treatment for Age-Related Macular Degeneration

FDA · Age-Related Macular Degeneration · 6 min

Dr. Sarah Mitchell
High impact NewsApr 11, 2026

FDA Approves NasoClear: First Nasal Spray for Pediatric RSV

FDA · Pediatric Infectious Diseases · 6 min

Dr. Sarah Mitchell
High impact NewsApr 10, 2026

FDA Approves Revitalize: Breakthrough for Chronic Fatigue Syndrome

FDA · Chronic Fatigue Syndrome · 6 min

Dr. Sarah Mitchell
Standard impact AnalysisApr 10, 2026

AI in FDA Drug Approvals: What You Need to Know

FDA · Pharmaceutical development · 10 min

Dr. Sarah Mitchell
High impact NewsApr 10, 2026

FDA Approves GeneCorrect: GeneTech's Breakthrough Cystic Fibrosis Therapy

FDA · Cystic Fibrosis · 7 min

Dr. Sarah Mitchell
High impact NewsApr 10, 2026

FDA Approves MyoRepair: Breakthrough Therapy for Heart Failure

FDA · Heart Failure · 7 min

Dr. Sarah Mitchell
High impact NewsApr 10, 2026

FDA Approval OncoBlock: Accelerated Approval for Refractory AML

FDA · Acute Myeloid Leukemia · 6 min

Dr. Sarah Mitchell
High impact NewsApr 10, 2026

FDA Approves Xylocor: Novel Advanced Melanoma Treatment by Xylos Bio

FDA · Advanced Melanoma · 6 min

Dr. Sarah Mitchell
High impact NewsApr 9, 2026

FDA Approves Opdivo for Advanced Renal Cell Carcinoma

FDA · renal cell carcinoma · 5 min

Dr. Sarah Mitchell
High impact NewsApr 9, 2026

FDA Approves Keytruda for Adjuvant Treatment of Stage III Melanoma

FDA · oncology · 4 min

Dr. Sarah Mitchell